{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-21-003010","form_type":"8-K","ticker":"CNBX","cik":"0001343009","company_name":"CNBX Pharmaceuticals Inc.","filed_at":"2021-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.775737+00:00","generated_at":"2026-06-30T04:25:51.244381+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Cannabics Pharmaceuticals appoints Dr. Gil Feiler as Independent Board Member","bullets":["Dr. Gil Feiler appointed as Independent Board Member effective July 15, 2021.","Feiler brings 25+ years executive experience; director of Bank of Georgia, former board member of First International Bank of Israel.","Feiler also heads company's Advisory Board; holds BA, MA, and PhD from Tel Aviv University.","Appointment made by Board resolution; no other changes to board or management disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-21-003010","json":"https://secwatch.observer/filing/0001683168-21-003010.json","markdown":"https://secwatch.observer/filing/0001683168-21-003010.md","text":"https://secwatch.observer/filing/0001683168-21-003010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1343009/000168316821003010/0001683168-21-003010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1343009/000168316821003010/cannabics_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T04:25:51.244381+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c72ddf1ada","claim":"Dr. Gil Feiler was appointed as Independent Board Member at CNBX Pharmaceuticals Inc..","evidence_excerpt":"On July 15th, 2021, the Board of Directors appointed Dr. Gil Feiler as an Independent Board Member","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1343009/000168316821003010/0001683168-21-003010-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Independent Board Member"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}